On April 8, 2022, a panel of the Inquiry Committee approved a Consent Agreement under which the Registrant agreed to remedial terms to address practice issues that occurred between April 2020 and January 2021 involving not meeting established standards of practice relating to documentation, medication administration, and therapeutic relationships.
The Registrant has voluntarily agreed to terms equivalent to a limit and/or condition on their practice, including:
A limit prohibiting them from practising in the community, engaging in autonomous practice, or working in a clinical setting with little oversight for a term.
A limit that they not be assigned students or be involved in the orientation of new staff for a term.
A limit that they must develop and follow a Learning Plan to address the concerns that gave rise to the BCCNM complaint.
Completing remedial courses covering topics of clinical decision-making, medication administration, and therapeutic relationships.
A referral to a Regulatory Practice Consultant at BCCNM.
The name of the Registrant has been withheld in accordance with section 39.3 (4) (a) of the Health Professions Act for the purposes of not identifying the personal health information of the Registrant respecting the condition.
The Inquiry Committee is satisfied that the undertakings will protect the public.